(Q27027281)

antineoplastic combined chemotherapy protocols

9 September 2020

1 reference

23 September 2020

1 reference

P Macaskill

2

0 references

Francesco Sardanelli

object named as

F Sardanelli

4

0 references

author name string

M L Marinovich

1

1 reference

L Irwig

3

1 reference

G von Minckwitz

5

1 reference

E Mamounas

6

1 reference

M Brennan

7

1 reference

S Ciatto

8

1 reference

N Houssami

9

1 reference

British Journal of Cancer

language of work or name

1 reference

17 September 2013

7 references

13 March 2019

3 April 2019

17 June 2019

25 June 2019

9 September 2020

23 September 2020

7 references

13 March 2019

3 April 2019

17 June 2019

25 June 2019

9 September 2020

23 September 2020

109

1 reference

issue

6

1 reference

page(s)

1528-36

1 reference

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

copyright license

6 references

13 March 2019

3 April 2019

17 June 2019

25 June 2019

9 September 2020

on focus list of Wikimedia project

23 September 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Measuring inconsistency in meta-analyses

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Statistical methods for assessing agreement between two methods of clinical measurement

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

MRI in breast cancer therapy monitoring

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Quality of life after breast conservation or mastectomy: a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

The effect of tissue fixation and processing on breast cancer size

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy

31 May 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

MRI and conservative treatment of locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Does breast cancer tumor size really matter that much?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

When Should a New Test Become the Current Reference Standard?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Dynamic contrast-enhanced MRI and sonography in patients receiving primary chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776985

Accurate determination of breast cancer size: The role of histopathology and imaging

28 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.473

Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?

21 January 2018

1 reference

12 December 2020

MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation

1 reference

12 December 2020

Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI

1 reference

12 December 2020

Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer

1 reference

12 December 2020

Accuracy of MRI in the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy

1 reference

12 December 2020

Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy

1 reference

12 December 2020

Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study

1 reference

12 December 2020

Commentary. Are current tumour response criteria relevant for the 21st century?

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2013.473

1 reference

Dimensions Publication ID

1018225294

0 references

1 reference

1 reference

PubMed publication ID

23963140

1 reference